Literature DB >> 34690596

Personality Disorders in Older Age.

Chevelle Brudey1.   

Abstract

Personality disorders are among the most common mental disorders in older age and are associated with a range of negative outcomes in physical and emotional health as well as in interpersonal functioning. Several screening tools have been validated with older patients and can aid in diagnosis. The presence of a personality disorder is associated with increased risk of cognitive decline, and cognitive disorders may mimic personality disorders. As a result, an evaluation of cognitive function is an essential part of assessing for a personality disorder. Emerging evidence points to the promise of dialectical behavioral therapy and schema therapy for older patients with personality disorders. Second-generation antipsychotics and mood stabilizers have been found to be effective for some personality disorders in the general adult population, but no such studies have been conducted with older adults.
Copyright © 2021 by the American Psychiatric Association.

Entities:  

Keywords:  Personality disorder; aging; geriatric psychiatry; obsessive-compulsive disorder

Year:  2021        PMID: 34690596      PMCID: PMC8475927          DOI: 10.1176/appi.focus.20210007

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  24 in total

1.  A Systematic Review of Personality Disorders and Health Outcomes.

Authors:  Katherine L Dixon-Gordon; Diana J Whalen; Brianne K Layden; Alexander L Chapman
Journal:  Can Psychol       Date:  2015-10-15

2.  Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.

Authors:  Thomas H Loew; Marius K Nickel; Moritz Muehlbacher; Patrick Kaplan; Cerstin Nickel; Christian Kettler; Rainhold Fartacek; Claas Lahmann; Wiebke Buschmann; Karin Tritt; Egon Bachler; Ferdinand Mitterlehner; Francisco Pedrosa Gil; Peter Leiberich; Wolfhardt K Rother; Christoph Egger
Journal:  J Clin Psychopharmacol       Date:  2006-02       Impact factor: 3.153

3.  Schema therapy for personality disorders in older adults: a multiple-baseline study.

Authors:  Arjan C Videler; Sebastiaan P J van Alphen; Rita J J van Royen; Christina M van der Feltz-Cornelis; Gina Rossi; Arnoud Arntz
Journal:  Aging Ment Health       Date:  2017-04-21       Impact factor: 3.658

4.  Personality and Cognitive Decline in Older Adults: Data From a Longitudinal Sample and Meta-Analysis.

Authors:  Martina Luchetti; Antonio Terracciano; Yannick Stephan; Angelina R Sutin
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2015-01-12       Impact factor: 4.077

Review 5.  Personality disorders in older adults: emerging research issues.

Authors:  S P J van Alphen; S D M van Dijk; A C Videler; G Rossi; E Dierckx; F Bouckaert; R C Oude Voshaar
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

6.  The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.

Authors:  Margaret M McClure; Deanna M Barch; Michelle J Romero; Michael J Minzenberg; Joseph Triebwasser; Philip D Harvey; Larry J Siever
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

Review 7.  Evidence-based pharmacotherapy for personality disorders.

Authors:  Luis H Ripoll; Joseph Triebwasser; Larry J Siever
Journal:  Int J Neuropsychopharmacol       Date:  2011-02-15       Impact factor: 5.176

8.  Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.

Authors:  Eric Hollander; Alan C Swann; Emil F Coccaro; Ping Jiang; Thomas B Smith
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

Review 9.  Suicidality in Borderline Personality Disorder.

Authors:  Joel Paris
Journal:  Medicina (Kaunas)       Date:  2019-05-28       Impact factor: 2.430

Review 10.  Personality Disorders in Older Adults: a Review of Epidemiology, Assessment, and Treatment.

Authors:  Krystle A P Penders; Inge G P Peeters; Job F M Metsemakers; Sebastiaan P J van Alphen
Journal:  Curr Psychiatry Rep       Date:  2020-02-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.